THYM, SKCM (Skin Cutaneous Melanoma), LAML, GBM, BLCA patients with mutation of NUDCD1-related gene set suggests shorter survival than those in the WT group (Figure 9I). This evidence concerns the gene NUDCD1 and glioblastoma.